{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:49:34Z","timestamp":1795124974280,"version":"4.10.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA254367"],"award-info":[{"award-number":["R01CA254367"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P01HD057877"],"award-info":[{"award-number":["P01HD057877"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      More than 70% of leiomyomas (LM) harbor\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations, primarily in exon 2 at c.130-131(GG). The cause of\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations in myometrial cells remains largely unknown. We hypothesized that increased ROS promotes\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations in myometrial cells through the oxidation of guanine nucleotides followed by misrepair.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Genomic oxidative burden (8-OHdG) was evaluated in vitro and in vivo by immunohistochemistry.\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations were examined by Sanger sequencing and deep sequencing. Transcriptome examined by RNA-seq was performed in myometrium with and without LM, in primary myometrial cells treated with ROS. 8-OHdG mediated misrepair was analyzed by CRISPR\/Cas9.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Uteri with high LM burden had a significantly higher rate of\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations than uteri with low LM burden. Compelling data suggest that the uterus normally produces reactive oxidative species (ROS) in response to stress, and ROS levels in LM are elevated due to metabolic defects. We demonstrated that genomic oxidized guanine (8-OHdG) was found at a significantly higher level in the myometrium of uteri that had multiple LM compared to myometrium without LM. Transcriptome and pathway analyses detected ROS stress in myometrium with LM. Targeted replacement of guanine with 8-OHdG at\n                      <jats:italic>MED12<\/jats:italic>\n                      c.130 by CRISPR\/Cas9 significantly increased the misrepair of G&gt;T. Exposure of primary myometrial cells to oxidative stress\n                      <jats:italic>in vitro<\/jats:italic>\n                      increased misrepair\/mutations as detected by duplex sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Together, our data identified a clear connection between increased myometrial oxidative stress and a high rate of\n                      <jats:italic>MED12<\/jats:italic>\n                      mutations that may underlie the risk of LM development and severity in women of reproductive age.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-022-00852-0","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T09:03:48Z","timestamp":1658480628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Myometrial oxidative stress drives MED12 mutations in leiomyoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Yinuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan F.","family":"Kohrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Julie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-2793","authenticated-orcid":false,"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"14","key":"852_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344\u201355.","journal-title":"N Engl J Med"},{"issue":"1","key":"852_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fertnstert.2010.08.049","volume":"95","author":"WH Catherino","year":"2011","unstructured":"Catherino WH, Parrott E, Segars J. Proceedings from the National Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertil Steril. 2011;95(1):9\u201312.","journal-title":"Fertil Steril"},{"issue":"3","key":"852_CR3","doi-asserted-by":"publisher","first-page":"211. e211-219","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211. e211-219.","journal-title":"Am J Obstet Gynecol"},{"issue":"6053","key":"852_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334(6053):252\u20135.","journal-title":"Science"},{"issue":"8","key":"852_CR5","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch E, Qiang W, Zhang Q, Espona-Fiedler M, Druschitz S, Liu Y, Mittal K, Kong B, Kurita T, Wei JJ. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol. 2014;27(8):1144\u201353.","journal-title":"Mod Pathol"},{"issue":"3","key":"852_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1128\/MCB.00993-08","volume":"29","author":"MT Knuesel","year":"2009","unstructured":"Knuesel MT, Meyer KD, Donner AJ, Espinosa JM, Taatjes DJ. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol Cell Biol. 2009;29(3):650\u201361.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"852_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PloS one. 2012;7(3): e33251.","journal-title":"PloS one"},{"issue":"6","key":"852_CR8","doi-asserted-by":"publisher","first-page":"E1044","DOI":"10.1002\/ijc.27610","volume":"131","author":"EM Je","year":"2012","unstructured":"Je EM, Kim MR, Min KO, Yoo NJ, Lee SH. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer. 2012;131(6):E1044-1047.","journal-title":"Int J Cancer"},{"issue":"6","key":"852_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.fertnstert.2017.04.015","volume":"107","author":"NM Fletcher","year":"2017","unstructured":"Fletcher NM, Abusamaan MS, Memaj I, Saed MG, Al-Hendy A, Diamond MP, Saed GM. Oxidative stress: a key regulator of leiomyoma cell survival. Fertil Steril. 2017;107(6):1387\u201394.","journal-title":"Fertil Steril"},{"issue":"7","key":"852_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0891-5849(00)00358-0","volume":"29","author":"M Foksinski","year":"2000","unstructured":"Foksinski M, Kotzbach R, Szymanski W, Olinski R. The level of typical biomarker of oxidative stress 8-hydroxy-2\u2019-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor. Free Radic Biol Med. 2000;29(7):597\u2013601.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"852_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2017.10.003","volume":"27","author":"MJ Torres","year":"2018","unstructured":"Torres MJ, Kew KA, Ryan TE, Pennington ER, Lin CT, Buddo KA, Fix AM, Smith CA, Gilliam LA, Karvinen S, et al. 17beta-estradiol directly lowers mitochondrial membrane microviscosity and improves bioenergetic function in skeletal muscle. Cell Metab. 2018;27(1):167\u201379.","journal-title":"Cell Metab"},{"issue":"11","key":"852_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601132","volume":"2","author":"V Vidimar","year":"2016","unstructured":"Vidimar V, Gius D, Chakravarti D, Bulun SE, Wei JJ, Kim JJ. Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas. Sci Adv. 2016;2(11): e1601132.","journal-title":"Sci Adv"},{"issue":"9","key":"852_CR13","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/1933719114522552","volume":"21","author":"NM Fletcher","year":"2014","unstructured":"Fletcher NM, Saed MG, Abuanzeh S, Abu-Soud HM, Al-Hendy A, Diamond MP, Saed GM. Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma. Reprod Sci. 2014;21(9):1145\u201352.","journal-title":"Reprod Sci"},{"issue":"1\u20132","key":"852_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mrfmmm.2011.02.015","volume":"711","author":"D Ziech","year":"2011","unstructured":"Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)\u2013induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711(1\u20132):167\u201373.","journal-title":"Mutat Res"},{"issue":"1","key":"852_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1): a001008.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"852_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.csbj.2019.12.013","volume":"18","author":"AR Poetsch","year":"2020","unstructured":"Poetsch AR. The genomics of oxidative DNA damage, repair, and resulting mutagenesis. Comput Struct Biotechnol J. 2020;18:207\u201319.","journal-title":"Comput Struct Biotechnol J"},{"issue":"58","key":"852_CR17","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1038\/sj.onc.1206023","volume":"21","author":"M Sekiguchi","year":"2002","unstructured":"Sekiguchi M, Tsuzuki T. Oxidative nucleotide damage: consequences and prevention. Oncogene. 2002;21(58):8895\u2013904.","journal-title":"Oncogene"},{"issue":"1","key":"852_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","volume":"267","author":"KC Cheng","year":"1992","unstructured":"Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G\u2013\u2013T and A\u2013\u2013C substitutions. J Biol Chem. 1992;267(1):166\u201372.","journal-title":"J Biol Chem"},{"issue":"23","key":"852_CR19","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.3390\/ijms20236092","volume":"20","author":"TH Lee","year":"2019","unstructured":"Lee TH, Kang TH. DNA Oxidation and Excision Repair Pathways. Int J Mol Sci. 2019;20(23):6092.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"852_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/biom9110735","volume":"9","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735.","journal-title":"Biomolecules"},{"issue":"12","key":"852_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/s41374-018-0117-5","volume":"98","author":"J Xie","year":"2018","unstructured":"Xie J, Xu X, Yin P, Li Y, Guo H, Kujawa S, Chakravarti D, Bulun S, Kim JJ, Wei JJ. Application of ex-vivo spheroid model system for the analysis of senescence and senolytic phenotypes in uterine leiomyoma. Lab Invest. 2018;98(12):1575\u201387.","journal-title":"Lab Invest"},{"key":"852_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1210\/en.2017-03191","volume":"159","author":"V Vidimar","year":"2018","unstructured":"Vidimar V, Chakravarti D, Bulun SE, Yin P, Nowak R, Wei JJ, Kim JJ. The AKT\/BCL-2 axis mediates survival of uterine leiomyoma in a novel 3D spheroid model. Endocrinology. 2018;159:1453.","journal-title":"Endocrinology"},{"issue":"36","key":"852_CR23","doi-asserted-by":"publisher","first-page":"14508","DOI":"10.1073\/pnas.1208715109","volume":"109","author":"MW Schmitt","year":"2012","unstructured":"Schmitt MW, Kennedy SR, Salk JJ, Fox EJ, Hiatt JB, Loeb LA. Detection of ultra-rare mutations by next-generation sequencing. Proc Natl Acad Sci USA. 2012;109(36):14508\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"852_CR24","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/nprot.2014.170","volume":"9","author":"SR Kennedy","year":"2014","unstructured":"Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, Ahn EH, Prindle MJ, Kuong KJ, Shen JC, Risques RA, et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nat Protoc. 2014;9(11):2586\u2013606.","journal-title":"Nat Protoc"},{"issue":"1","key":"852_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/nar\/gky1152","volume":"47","author":"S Amente","year":"2019","unstructured":"Amente S, Di Palo G, Scala G, Castrignano T, Gorini F, Cocozza S, Moresano A, Pucci P, Ma B, Stepanov I, et al. Genome-wide mapping of 8-oxo-7,8-dihydro-2\u2019-deoxyguanosine reveals accumulation of oxidatively-generated damage at DNA replication origins within transcribed long genes of mammalian cells. Nucleic Acids Res. 2019;47(1):221\u201336.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"852_CR26","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/s41467-020-16361-y","volume":"11","author":"PC Pao","year":"2020","unstructured":"Pao PC, Patnaik D, Watson LA, Gao F, Pan L, Wang J, Adaikkan C, Penney J, Cam HP, Huang WC, et al. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease. Nat Commun. 2020;11(1):2484.","journal-title":"Nat Commun"},{"key":"852_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dnarep.2014.01.003","volume":"15","author":"M Yasui","year":"2014","unstructured":"Yasui M, Kanemaru Y, Kamoshita N, Suzuki T, Arakawa T, Honma M. Tracing the fates of site-specifically introduced DNA adducts in the human genome. DNA Repair (Amst). 2014;15:11\u201320.","journal-title":"DNA Repair (Amst)"},{"issue":"19","key":"852_CR28","doi-asserted-by":"publisher","first-page":"9049","DOI":"10.1093\/nar\/gkt555","volume":"41","author":"L Yang","year":"2013","unstructured":"Yang L, Guell M, Byrne S, Yang JL, De Los Angeles A, Mali P, Aach J, Kim-Kiselak C, Briggs AW, Rios X, et al. Optimization of scarless human stem cell genome editing. Nucleic Acids Res. 2013;41(19):9049\u201361.","journal-title":"Nucleic Acids Res"},{"key":"852_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.12688\/f1000research.14227.2","volume":"7","author":"J Bullerdiek","year":"2018","unstructured":"Bullerdiek J, Rommel B. Factors targeting MED12 to drive tumorigenesis? F1000Res. 2018;7:359.","journal-title":"F1000Res"},{"issue":"1","key":"852_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41598-017-01199-0","volume":"7","author":"HR Heinonen","year":"2017","unstructured":"Heinonen HR, Pasanen A, Heikinheimo O, Tanskanen T, Palin K, Tolvanen J, Vahteristo P, Sjoberg J, Pitkanen E, Butzow R, et al. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci Rep. 2017;7(1):1015.","journal-title":"Sci Rep"},{"issue":"12","key":"852_CR31","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-07-6339","volume":"68","author":"A Mayer","year":"2008","unstructured":"Mayer A, Hockel M, Wree A, Leo C, Horn LC, Vaupel P. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res. 2008;68(12):4719\u201326.","journal-title":"Cancer Res"},{"issue":"9","key":"852_CR32","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1210\/en.2014-1029","volume":"155","author":"B Wu","year":"2014","unstructured":"Wu B, Chen X, He B, Liu S, Li Y, Wang Q, Gao H, Wang S, Liu J, Zhang S, et al. ROS are critical for endometrial breakdown via NF-kappaB-COX-2 signaling in a female mouse menstrual-like model. Endocrinology. 2014;155(9):3638\u201348.","journal-title":"Endocrinology"},{"issue":"4","key":"852_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/15287390600974924","volume":"10","author":"D Roy","year":"2007","unstructured":"Roy D, Cai Q, Felty Q, Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev. 2007;10(4):235\u201357.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"10","key":"852_CR34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00109-018-1682-1","volume":"96","author":"X Xu","year":"2018","unstructured":"Xu X, Kim JJ, Li Y, Xie J, Shao C, Wei JJ. Oxidative stress-induced miRNAs modulate AKT signaling and promote cellular senescence in uterine leiomyoma. J Mol Med (Berl). 2018;96(10):1095\u2013106.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"852_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab JE, Zou X, Morganella S, Joel M, Nanda AS, Nagy E, Gomez C, Degasperi A, Harris R, Jackson SP, et al. A compendium of mutational signatures of environmental agents. Cell. 2019;177(4):821\u201336.","journal-title":"Cell"},{"issue":"8","key":"852_CR36","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/ng.3037","volume":"46","author":"WK Lim","year":"2014","unstructured":"Lim WK, Ong CK, Tan J, Thike AA, Ng CC, Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 2014;46(8):877\u201380.","journal-title":"Nat Genet"},{"issue":"4","key":"852_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012583","volume":"5","author":"HE Krokan","year":"2013","unstructured":"Krokan HE, Bjoras M. Base excision repair. Cold Spring Harb Perspect Biol. 2013;5(4): a012583.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7147","key":"852_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nature05978","volume":"447","author":"SS David","year":"2007","unstructured":"David SS, O\u2019Shea VL, Kundu S. Base-excision repair of oxidative DNA damage. Nature. 2007;447(7147):941\u201350.","journal-title":"Nature"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-022-00852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-022-00852-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-022-00852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T09:08:08Z","timestamp":1658480888000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-022-00852-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/s13578-022-00852-0","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Northwestern University IRB and study biospecimens were from consented patients. YL, XX, YF, BFK, SRK, JJK, JJW","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the participants of this study consented to the publication of this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}